122 related articles for article (PubMed ID: 8057094)
21. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
Unger L; Kampf S; Lüthke K; Aringer M
Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
[TBL] [Abstract][Full Text] [Related]
22. Methylprednisolone pulse therapy in dermatomyositis.
Yanagisawa T; Sueishi M; Nawata Y; Akimoto T; Nozaki T; Koike T; Tomioka H; Kumagai A
Dermatologica; 1983; 167(1):47-51. PubMed ID: 6628798
[TBL] [Abstract][Full Text] [Related]
23. Effect of early treatment in polymyositis and dermatomyositis.
Naji P; Shahram F; Nadji A; Davatchi F
Neurol India; 2010; 58(1):58-61. PubMed ID: 20228465
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis].
Ito S; Miyamae T; Imagawa T; Katakura S; Mori M; Tomono J; Ibe M; Mituda T; Aihara Y; Yokota S
Ryumachi; 1998 Dec; 38(6):785-92. PubMed ID: 10047716
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and limitations of pulse cyclophosphamide therapy in polymyositis and dermatomyositis.
Nagappa M; Taly AB; Sinha S; Gayathri N; Bindu PS; Mahadevan A; Yasha T
J Clin Neuromuscul Dis; 2013 Jun; 14(4):161-8. PubMed ID: 23703010
[TBL] [Abstract][Full Text] [Related]
26. Higher proportion of fast-twitch (type II) muscle fibres in idiopathic inflammatory myopathies - evident in chronic but not in untreated newly diagnosed patients.
Loell I; Helmers SB; Dastmalchi M; Alexanderson H; Munters LA; Nennesmo I; Lindroos E; Borg K; Lundberg IE; Esbjörnsson M
Clin Physiol Funct Imaging; 2011 Jan; 31(1):18-25. PubMed ID: 21029327
[TBL] [Abstract][Full Text] [Related]
27. [Dermatomyositis and polymyositis: clinical aspects and treatment].
Hachulla E
Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
Aslanidis S; Pyrpasopoulou A; Kartali N; Zamboulis C
Clin Rheumatol; 2007 Jul; 26(7):1198-200. PubMed ID: 16779504
[TBL] [Abstract][Full Text] [Related]
29. Use of methotrexate in inflammatory myopathies.
Fendler C; Braun J
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
[TBL] [Abstract][Full Text] [Related]
30. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
Chérin P; Herson S
Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of refractory polymyositis with pulse intravenous cyclophosphamide and low-dose weekly oral methotrexate therapy.
Hirano F; Tanaka H; Nomura Y; Matsui T; Makino Y; Fukawa E; Miura T; Makino I
Intern Med; 1993 Sep; 32(9):749-52. PubMed ID: 8142684
[TBL] [Abstract][Full Text] [Related]
32. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.
Tsounis M; Psillas G; Tsalighopoulos M; Vital V; Maroudias N; Markou K
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):103-110. PubMed ID: 29168028
[TBL] [Abstract][Full Text] [Related]
33. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.
Efthimiou P; Schwartzman S; Kagen LJ
Ann Rheum Dis; 2006 Sep; 65(9):1233-6. PubMed ID: 16476710
[TBL] [Abstract][Full Text] [Related]
34. High-dose intravenous methyl-prednisolone in chronic polymyositis/dermatomyositis.
Castro-Gago M; Alvez-Gonzalez F; Peña-Guitián J
Brain Dev; 1986; 8(5):570. PubMed ID: 3799928
[No Abstract] [Full Text] [Related]
35. [Intravenous immunoglobulins in chronic idiopathic myositis].
Michels H; Burmester GR; Buttgereit F
Z Rheumatol; 2005 Mar; 64(2):102-10. PubMed ID: 15793676
[No Abstract] [Full Text] [Related]
36. Dermatomyositis associated with small cell carcinoma of the lung: dramatic response to corticosteroid therapy.
Labinjoh C; Selby C
Respir Med; 1998 Mar; 92(3):601-2. PubMed ID: 9692132
[No Abstract] [Full Text] [Related]
37. [Long-term study of diffuse connective tissue disease after methylprednisolone pulsed therapy].
Hrncír Z; Bradna P; Nozicková H; Tichý M
Vnitr Lek; 1991 Jan; 37(1):63-72. PubMed ID: 2058099
[TBL] [Abstract][Full Text] [Related]
38. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous amyloidosis associated with amyopathic dermatomyositis.
Taniguchi Y; Horino T; Terada Y
J Rheumatol; 2009 May; 36(5):1088-9. PubMed ID: 19435977
[No Abstract] [Full Text] [Related]
40. Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations.
Hengstman GJ; van den Hoogen FH; Barrera P; Netea MG; Pieterse A; van de Putte LB; van Engelen BG
Eur Neurol; 2003; 50(1):10-5. PubMed ID: 12824706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
